205 related articles for article (PubMed ID: 16077361)
21. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
[TBL] [Abstract][Full Text] [Related]
22. Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases.
Opremcak EM; Rehmar AJ; Ridenour CD; Kurz DE; Borkowski LM
Retina; 2006 Mar; 26(3):306-13. PubMed ID: 16508431
[TBL] [Abstract][Full Text] [Related]
23. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
24. Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion.
Muqit MM; Saidkasimova S; Keating D; Murdoch JR
Acta Ophthalmol; 2010 May; 88(3):e57-65. PubMed ID: 20222903
[TBL] [Abstract][Full Text] [Related]
25. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study.
Glacet-Bernard A; Kuhn D; Vine AK; Oubraham H; Coscas G; Soubrane G
Br J Ophthalmol; 2000 Jun; 84(6):609-13. PubMed ID: 10837386
[TBL] [Abstract][Full Text] [Related]
26. Three treatments for macular edema because of branch retinal vein occlusion: intravitreous bevacizumab or tissue plasminogen activator, and vitrectomy.
Kumagai K; Ogino N; Furukawa M; Larson E
Retina; 2012 Mar; 32(3):520-9. PubMed ID: 21811207
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
[TBL] [Abstract][Full Text] [Related]
28. Post-vitrectomy tissue plasminogen activator injection for central retinal vein occlusion.
Christodoulakis EV; Tsilimbaris MK
Ophthalmic Surg Lasers Imaging; 2008; 39(3):252-6. PubMed ID: 18556955
[TBL] [Abstract][Full Text] [Related]
29. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
[TBL] [Abstract][Full Text] [Related]
30. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
31. Visual outcomes in five different approaches for treatment of central retinal vein occlusion.
Soheilian M; Ramezani A; Tavallali A; Mohebbi MR; Peyman GA
Ophthalmic Surg Lasers Imaging; 2010; 41(2):157-65. PubMed ID: 20307032
[TBL] [Abstract][Full Text] [Related]
32. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
Wang L; Song H
Acta Ophthalmol; 2009 May; 87(3):285-9. PubMed ID: 18507724
[TBL] [Abstract][Full Text] [Related]
33. Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion.
Chuang LH; Yeung L; Wang NK; Chen HS; Ku WC; Lai CC
J Ocul Pharmacol Ther; 2010 Aug; 26(4):325-8. PubMed ID: 20653482
[TBL] [Abstract][Full Text] [Related]
34. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous intravitreal injection of triamcinolone acetonide and tissue plasminogen activator for central retinal vein occlusion: a pilot study.
Yamamoto T; Kamei M; Sayanagi K; Matsumura N; Nishida K; Sakaguchi H; Tsujikawa M; Tano Y
Br J Ophthalmol; 2011 Jan; 95(1):69-73. PubMed ID: 20494908
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion.
Amirikia A; Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ
Ophthalmology; 2001 Feb; 108(2):372-6. PubMed ID: 11158815
[TBL] [Abstract][Full Text] [Related]
38. Effects of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusion.
Ozdek SC; Aydin B; Gürelik G; Bahçeci U; Hasanreisoğlu B
Int Ophthalmol; 2005; 26(1-2):27-34. PubMed ID: 16783483
[TBL] [Abstract][Full Text] [Related]
39. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide.
Jonas JB; Akkoyun I; Kamppeter B; Kreissig I; Degenring RF
Eye (Lond); 2005 Jan; 19(1):65-71. PubMed ID: 15105817
[TBL] [Abstract][Full Text] [Related]
40. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
